Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02583191
Recruitment Status : Terminated (Recruitment was not as expected.)
First Posted : October 22, 2015
Last Update Posted : May 3, 2021
Sponsor:
Collaborators:
Charite University, Berlin, Germany
Bayer
Information provided by (Responsible Party):
AIO-Studien-gGmbH

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 11, 2019
Actual Study Completion Date : August 19, 2019